Lost Password? No account yet? Register

Advertisement

New Media Advertisement
Rationalization of rate of duty on pharma products PDF Print E-mail
User Rating: / 0
PoorBest 
Written by Administrator   
Tuesday, 18 March 2008

Pharma units are eligible for general small-scale industries excise duty exemption scheme. As such, units having clearance value upto Rs 4 crore in the preceding financial year are eligible for full excise duty exemption on their first clearances upto Rs 1.5 crore in a financial year, subject to certain conditions.

In the States of Uttarakhand & Himachal Pradesh, new units or units undertaking substantial expansion are fully exempt from excise duty, while such units in the North East, Jammu & Kashmir and Kutch are entitled for refund of duty paid in cash.

In the budget 2008-09, the issue of excise duty on pharma products was examined and excise duty on pharmaceutical products including drugs has been reduced from 16% to 8%. The tax-exemption under small-scale exemption scheme was also examined and it was decided not to make any change for the present.

 

 
< Prev   Next >

11.03.2008 | Retailing

Kmart Pharmacy has launch of the American Fare Dollar Program, which offers pharmacy customers a choice of 10 over-the-counter (OTC) medications from Kmart's proprietary American Fare brand for only…     Readmore

Image

09.09.2007 | Outsourcing

The pharmaceutical manufacturers in the United States have attacked the proposed pharma policy of India saying that it would contravene the stated goal of liberalizing the sector, and sought some…     Readmore

Image

09.09.2007 | Homeopathy

The Homeopatic manufacturing units must fulfill the conditions stated by the government of India under 67-G     Readmore

10.07.2008 | FDA

Invitrogen Corporation, a provider of essential life science technologies for research, production and diagnostics,  has received U.S. Food and Drug Administration (FDA) premarket approval (PMA) for its SPOT-Light(R) HER2…     Readmore

17.07.2008 | Biotechnology

Angel Biotechnology Holdings plc, the biopharmaceutical contract manufacturer, is announced pre-GMP process development programme with Angport Limited. The contract is the first to be signed under the EPhaG relationship…     Readmore

07.10.2008 | Nanotechnology

Cambridge is one of four institutes located outside of Japan which will host a satellite of the 'International Center for Materials Nanoarchitectonics' (MANA). (The University of California, Los Angeles,…     Readmore

20.12.2007 | Packaging

Bilcare Research has launched a product to help check the menace of counterfeit drugs. The product has a label with a unique bar code made out of nanotechnology and…     Readmore